Systematic structure guided clustering of chemical lead compounds targeting RdRp of SARS-CoV-2
Docking (animal)
Drug repositioning
DOCK
Drug target
DOI:
10.23736/s2724-542x.22.02869-3
Publication Date:
2022-09-16T12:20:04Z
AUTHORS (9)
ABSTRACT
BACKGROUND: To combat the global health issue caused by SARS-CoV2, scientists are attempting various therapeutic approaches towards drug discovery including computational biology and drug-repurposing. Recent studies have highlighted conserved nature of RNA-dependent RNA polymerase (RdRp) coronaviruses affecting human, bat animals. In this study attempts been made to identify potential inhibitors RdRp utilizing molecular docking MD simulation studies.METHODS: Systematic structure-based screening chemical compounds from public libraries was performed lead molecules inhibiting RdRp. This structure driven clustering is based on decision tree model generated combining two properties: 1) shape descriptors; 2) critical number multiple bonds. The enabled subjected followed dynamics studies.RESULTS: results revealed that stability protein-drug complex in order RdRp-Oxoglaucine >RdRp-Flutroline >RdRp-Brucine complex.CONCLUSIONS: identifies Oxoglaucine, Brucine Flutroline as prospective agents SARS-CoV-2 further warrants for experimental validation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....